Novatio Ventures is a leading brand that specializes in accelerating the commercialization of high-potential, high-impact life science innovations. With locations in Toronto, Boston, and Hong Kong, Novatio focuses on global development and investment opportunities in Canada, the U. S., China, South Korea, and other markets.

They primarily target early-stage innovations that are on the cusp of preclinical proof-of-concept or validation. Novatio provides seed funding and actively works with inventors, entrepreneurs, and institutions to devise and implement development and commercialization strategies. They assemble management teams and secure additional capital to support the growth and success of these innovative ventures.

Leveraging their collective experience and global industry network, Novatio aims to achieve early exits that generate attractive, risk-mitigated financial returns. The Novatio team consists of experts with deep investment, scientific, business development, capital market, IP, legal, and operational expertise. They have the necessary knowledge and skills to identify, evaluate, and secure promising new innovations for acceleration towards value creation.

In summary, Novatio Ventures is dedicated to bringing innovation to market by providing seed capital and management services. They play a crucial role in advancing groundbreaking life science technologies and fostering their success